Announcements Trials
Browse Landscape

Phase

Phase 2 232Phase 1 70Phase 3 44Phase 1/2 29Phase NA 23Phase 4 8Phase 2/3 3Phase EARLY_PHASE1 2

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2CNS 1

Conditions

Neoplasm Metastasis 1Liver Neoplasms 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Interventional × Sunitinib × Clear all
NCT01164202 2022-03-18

SATURNE

Federation Francophone de Cancerologie Digestive

Phase 2/3 Completed
78 enrolled 9 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03025893 2021-04-19

STELLAR

Amsterdam UMC, location VUmc

Phase 2/3 Unknown
100 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT03909724 2020-11-13

SUNRISE-CRC

Amsterdam UMC, location VUmc

Phase 2/3 Unknown
60 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡